Abstract
Objectives: To synthesize the prevalence of mental and substance use disorders in countries of the Eastern Mediterranean Region (EMR) of the World Health Organization.Methods: The literature search was conducted across several databases in two phases. First, we searched for systematic reviews and/or meta-analyses published before 2014, reporting prevalence estimates for mental disorders in the EMR. Then, we identified new primary cross-sectional or longitudinal studies published between 2014 and 2020. Studies were included if they had a sample size of ≥ 450 and were conducted among the general adult population. Current, period and lifetime prevalence estimates for each disorder were pooled using random-effects meta-analyses, and subgroup analyses and meta-regressions were conducted.Findings: Prevalence estimates were extracted from 54 cross-sectional studies across 15 countries within the EMR. Pooled analyses of current, period and lifetime prevalence showed the highest prevalence for depression (14.8%, 95% confidence interval, CI: 10.7–20.1%), followed by generalized anxiety disorder (GAD) (10.4%, 95% CI: 7.1–14.7%), post-traumatic stress disorder (7.2%, 95% CI: 2.9–16.6%), substance use (4.0%, 95% CI: 3.1–5.2%), obsessive compulsive disorder (2.8%, 95% CI: 1.6–4.9%), phobic disorders (1.8%, 95% CI: 1.1–2.8%), panic disorders (1.1%, 95% CI: 0.6–2.2%), bipolar disorders (0.7%, 95% CI: 0.3–1.6%), and psychosis (0.5%, 95% CI: 0.3–0.9%). Populations exposed to adverse events had higher prevalence of mental disorders than the general population. Period and lifetime prevalence showed little difference across mental disorders. More pronounced differences in prevalence were seen for depression and GAD, specifically between current and lifetime prevalence (depression: current prevalence 20.5% (95% CI: 14.9–27.4%), vs. lifetime prevalence: 4.2% (95%CI: 1.8–9.6%); GAD: current prevalence 10.3% (95% CI: 6.1–17.0), vs. lifetime prevalence: 4.5% (95% CI: 2.4–8.3%). Differences between current and lifetime prevalence of mental disorders may be due to the use of different screening instruments and thresholds being applied.Conclusion: The prevalence of mental and substance use disorders in the EMR is high. Despite substantial inter-survey heterogeneity, our estimates align with previous global and regional data on mental disorders. Our meta-review provides new evidence on the burden of mental health problems in the EMR.Systematic Review Registration: PROSPERO, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020187388.
Highlights
Mental disorders contribute significantly to the global burden of disease, with common mental disorders (CMDs) such as depression, anxiety and post-traumatic stress disorders (PTSD) accounting for 41.9% of the burden [1]
An extensive body of research suggests that the experience of war, conflict, population displacement, infrastructure damage and unemployment leads to increased symptoms of depression, anxiety, trauma and stress-related disorders [4], and this is evident in countries located in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO) in which the 12-month prevalence of CMDs ranges between 11 and 40.1% [5]
Sadeghirad et al reviewed the prevalence of major depressive disorder in Iran [9], and Mirza and Jenkins assessed the evidence on the prevalence of anxiety and depressive disorders in Pakistan [10]
Summary
Mental disorders contribute significantly to the global burden of disease, with common mental disorders (CMDs) such as depression, anxiety and post-traumatic stress disorders (PTSD) accounting for 41.9% of the burden [1]. Research suggests that prevalence of mental disorders is increasing in low-and-middle-income countries due to population growth and aging [3]. An extensive body of research suggests that the experience of war, conflict, population displacement, infrastructure damage and unemployment leads to increased symptoms of depression, anxiety, trauma and stress-related disorders [4], and this is evident in countries located in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO) in which the 12-month prevalence of CMDs ranges between 11 and 40.1% [5] (list of EMR member countries included in Annex 1). Travers et al synthesized evidence on the prevalence of major depressive disorder within Africa and the Middle East [7], and Naveed et al reported on the pooled prevalence of CMDs and substance use disorders in South Asia [8].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
